2005
DOI: 10.1007/s11940-005-0025-z
|View full text |Cite
|
Sign up to set email alerts
|

Central nervous system coccidioides immitis infections

Abstract: Coccidioidal meningitis occurs in healthy individuals and patients with AIDS or other immunosuppressive illnesses. The central nervous system infection results when Coccidioides immitis disseminates from a primary lung infection via a fungemia to reach the meninges. Cases develop primarily in individuals living in or traveling to the Lower Sonoran Life Zone of Southwest United States. Most cases begin as subacute granulomatous meningitis with occasional patients developing brain abscesses. Diagnosis may be cha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2016
2016

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…AmB is also effective for other mycoses such as aspergillosis, candidiasis, histoplasmosis, blastomycosis, coccidioidomycosis, sporotrichosis, fusariosis, and phaeohyphomycosis in the cases of lack of response to azoles or echinocandins. (Ellis, 2002; Davis and Porter, 2005; Metcalf and Dockrell, 2007; Chandrasekar, 2008; Gomez-Lopez et al, 2008; Muhammed et al, 2011). Additionally, AmB has activity against parasites as Trypanosoma cruzi , Schistosoma mansoni , Echinococcus multilocularis , and Leishmania spp, being the second drug of choice for the treatment for visceral leishmaniasis when antimonials fail or cannot be used (Yardley and Croft, 1999; Reuter et al, 2003; Mone et al, 2010; Paila et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…AmB is also effective for other mycoses such as aspergillosis, candidiasis, histoplasmosis, blastomycosis, coccidioidomycosis, sporotrichosis, fusariosis, and phaeohyphomycosis in the cases of lack of response to azoles or echinocandins. (Ellis, 2002; Davis and Porter, 2005; Metcalf and Dockrell, 2007; Chandrasekar, 2008; Gomez-Lopez et al, 2008; Muhammed et al, 2011). Additionally, AmB has activity against parasites as Trypanosoma cruzi , Schistosoma mansoni , Echinococcus multilocularis , and Leishmania spp, being the second drug of choice for the treatment for visceral leishmaniasis when antimonials fail or cannot be used (Yardley and Croft, 1999; Reuter et al, 2003; Mone et al, 2010; Paila et al, 2010).…”
Section: Introductionmentioning
confidence: 99%